News
European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...
34m
InvestorsHub on MSNDow Jones, S&P, Nasdaq, Wall Street Futures Inch Higher as Market Digests Earnings; Intel, Centene Sink, Deckers JumpsU.S. stock futures ticked up Friday morning, supported by a mostly upbeat earnings season even as several major names posted ...
Separately, Sareptea said last week that it would pause the development of most of its experimental gene therapies for a different type of muscular dystrophy. The stoppage came after one of the ...
The European Medicines Agency determined testing failed to prove Elevidys’ benefit and issued a negative opinion that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results